Skin cancer is the most common and fastest growing form of cancer in the world. The main risk factors for developing skin cancer include exposure to UV radiation, age, sex, ethnicity, occupation, and family history of skin cancer.
It is classified in 2 categories : melanoma, the deadliest form, and carcinoma, the most common type. Each year, skin cancer results in more than 10 thousands deaths, just in Europe. The incidence of the melanoma expands for several decades and doubles all 10 years since 1945 in the world.
DAMAE Medical is a French startup founded in September 2014, located in Paris, which currently employs a multidisciplinary team: advanced research in optics, product design & engineering, computer science, image science, clinical marketing development.
To improve skin cancer diagnosis, DAMAE Medical has developed a novel hand-held imaging device that allows a non-invasive 3D visualization of skin tissues. With a single contact on the skin, the device provides, in real time, images very similar to the histology images. The solution consists in bringing the microscope directly to the patient. The device relies on a unique patented approach combining Optical Coherence Tomography (OCT) with Confocal Microscopy (CM), called LC-OCT (Line-field Confocal OCT). The combination resolution + depth is really was differentiate them from the competition.
This technology was invented by Pr. Arnaud Dubois, co-founder and Chief Scientific Officer at DAMAE Medical, and developed in collaboration with CNRS, Institut d'Optique Graduate School and Université Paris-Sud.
LC-OCT is currently used in clinical studies for 3 main uses :
GOAL 3: GOOD HEALTH AND WELL-BEING
DAMAE Medical ensures healthy lives and promote well-being for all at all ages. DAMAE Medical is developing an in vivo skin imaging device based on the new LC-OCT technology to perform optical biopsies.
Thanks to Solidworks, the LC-OCT device was designed for an easy integration into hospitals, clinics and dermatological private practices. Main product features of LC-OCT device includes an easy-to-use handheld probe with embedded optical and electronics elements. DAMAE Medical is working on industrializing the device and preparing its production scale-up and market introduction. Dassault Systèmes and DAMAE Medical can make this dream happen by providing the 3DEXPERIENCE Cloud Platform to host, share and labellize LC-OCT clinical database.
The development process of a medical device can be rigid, particularly for a start-up. This is why we carry out iterative development cycles during the design and test phases. These principles consist in defining the key assumptions or specifications of the product to be validated, quickly developing a β version of the solution, testing it with market partners (hospitals, laboratories, manufacturers) and then collecting user feedback (on the functionalities, quality, usage, ergonomics, or bugs of the product), implementing them, and starting the loop over until optimal performance is achieved and market expectations are met.
DAMAE Medical has structured an agile flattened hierarchy, composed of high-level talented collaborators, self-directed, motivated, reliable, with a work-team mindset and key competencies to manage high added-value activities of the projects. This organization enables quick decisions, rapid evolutions and paves the way for continuous innovation and reinvention, to provide the market with the best solutions.
With studies estimating the annual number of deaths due to medical errors in the hundreds of thousands, the time has come to revise the way the medical profession gains knowledge and experience. Advances in 3D printing technology and virtual simulation are creating new opportunities to improve the quality of treatments and patient safety.
Have you been in a situation where a generic treatment did not work very well for you or someone you know? Have you ever had that nagging feeling that maybe the doctor (as good as he or she may be) should really be treating YOU rather than a generalized representation of you?
In the US, 1 child in 68 is born with the Autism Spectrum Disorders. Children with Autism have learning and developmental disorders, and represent a number higher than all others disabilities put together. In the US alone, over 6.4% children have special needs in terms of cognitive, motor and sensory processing skills.
The satellite market has been disrupted by the miniaturization of the technology. Lots of small satellites have been created and they aim to provide data for Earth observation, surveillance, telecommunications, smart cities, connectivity, meteorology, emergency responses, ...
Inaccurate medications kill 5 times more than road accidents in developed countries. Jus in France, they cost 10 billion euros to the public health system. Around the globe, consolidated numbers are not easily accessible but we estimate that inaccurate medications cause at least 1 million deaths and cost 1000 billion dollars to public health systems every year.
The Living Heart Project aims to advance the development of safe and effective cardiovascular products and treatments by uniting engineering, scientific, and biomedical expertise to translate cutting-edge science into improved patient care. Through simulation and the creation of validated models, the project aims to provide personalized, interventional patient care.
Two 3D experiences, ultra realistic on a scientific point of view, were created through collaborative projects with technologic and scientific partners: "Staying Alive" and "Born To Be Alive".
"Staying Alive" is a serious game that allows to learn appropriate behaviors for first aid techniques.
Long term recordings of patients is often difficult due to complexity of measurement, hospitalization cost, burden for patients or lack of availability of specialized Doctors. Yet, these long term recordings are critical for an accurate diagnosis and care plan setting, in many pathologies such as Epilepsy, Cardiovascular disease and Sleep disorders.
Do you think your project is the next big thing?
Join the team !